Literature DB >> 15835452

Meperidine (Demerol) safety issues.

Christine Koczmara1, Dan Perri, Sylvia Hyland, Lin Rousseaux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15835452

Source DB:  PubMed          Journal:  Dynamics        ISSN： 1497-3715


× No keyword cloud information.
  6 in total

1.  Intravenous dexmedetomidine for the treatment of shivering during Cesarean delivery under neuraxial anesthesia: a randomized-controlled trial.

Authors:  Christina Lamontagne; Sandra Lesage; Edith Villeneuve; Elsa Lidzborski; Alex Derstenfeld; Chantal Crochetière
Journal:  Can J Anaesth       Date:  2019-04-03       Impact factor: 5.063

2.  Voluntary warnings and the limits of good prescribing behavior: the case for de-adoption of meperidine.

Authors:  Kevin J Friesen; Jamie Falk; Shawn Bugden
Journal:  J Pain Res       Date:  2015-12-15       Impact factor: 3.133

3.  Chronopharmacodynamics and chronopharmacokinetics of pethidine in mice.

Authors:  Chengliang Zhang; Zaoqin Yu; Xiping Li; Yanjiao Xu; Dong Liu
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

4.  The safety of meperidine prescribing in older adults: A longitudinal population-based study.

Authors:  Kevin J Friesen; Jamie Falk; Shawn Bugden
Journal:  BMC Geriatr       Date:  2016-05-11       Impact factor: 3.921

5.  Nalbuphine versus dexmedetomidine for treatment of combined spinal-epidural post-anesthetic shivering in pregnant women undergoing cesarean section.

Authors:  Jing Sun; Zhao Zheng; Yi-Lu Li; Li-Wei Zou; Ge-Hui Li; Xiao-Guang Wang; Bao-Zuan She; Xiao-Lei Huang; Yuan-Tao Li
Journal:  J Int Med Res       Date:  2019-07-29       Impact factor: 1.671

6.  Conventional versus Analgesia-Oriented Combination Sedation on Recovery Profiles and Satisfaction after ERCP: A Randomized Trial.

Authors:  Seokyung Shin; Tak Geun Oh; Moon Jae Chung; Jeong Youp Park; Seung Woo Park; Jae Bok Chung; Si Young Song; Jooyoun Cho; Sang-Hun Park; Young Chul Yoo; Seungmin Bang
Journal:  PLoS One       Date:  2015-09-24       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.